Cells isolated from fat pad and synovial fluid. are they suitable for cartilage repair?  by Garica, J.K. et al.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S445expression levels of glycosaminoglycan (GAG) and target genes
including wnt1, wnt3a, wnt5a, wnt10b, b-catenin, sox9, runx2, osteo-
pontin, lipoprotein lipase, peroxisome proliferator-activated receptor
gamma (PPAR-g or PPARG), and collagen I, II, X mRNA on different
concentrations of TGF-b1 were detect by ELISA assay and ﬂuorescence
quantitative (FQ)-PCR, respectively.
Results: After cultured in the TGF-b1 medium for 14 days, BMSCs dif-
ferentiated into circular or polygonal cells. After 21 days, 95% of the cells
were circular or polygonal cells with blue secretory granules within the
cytoplasm by toluidine blue staining. Compared with the control group,
the content of GAG increased signiﬁcantly in the group of TGF-b1
medium, especially in 2ng/ml TGF-b1 group by ELISA method. FQ-PCR
results indicated that mRNA expression level of wnt1, wnt3a, wnt5a,
wnt10b and b-catenin after exposure to 2ng/ml TGF-b1 was obviously
suppressed compared with control group, and mRNA expression level
of sox9, collagen II was statistically enhanced, with an results of
inhibiting expression of runx2, osteopontin, lipoprotein lipase, PPAR-g,
and collagen I, X. Moreover, we found that the expression of chondro-
genic related genes was not upon a parallel line with the TGF-b1
concentration.
Conclusion: TGF-b1 can promote BMSCs differentiating into chon-
drocytes. During the differentiation progress, the expression of Wnt/b-
catenin signaling pathway related genes was inhibited and chon-
drocyte speciﬁc genes of sox9, collagen II mRNA were increased. TGF-b
may modulate chondrogenic differenciation though Wnt signaling
pathway.
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CELLS ISOLATED FROM FAT PAD AND SYNOVIAL FLUID. ARE THEY
SUITABLE FOR CARTILAGE REPAIR?
J.K. Garica, C. Mennan, J. Richardson, K. Wright, S. Roberts. Robert Jones
Agnes Hunt Hosp. (Keele Univ.), Oswestry, United Kingdom
Purpose: Autologous Chondrocyte Implantation (ACI) is used as a cel-
lular therapy for treating defects in articular cartilage. Successful ACI
depends on high cell number and quality of the cells which varies
between patients. Alternative cell sources within the joint may provide
a more preferable treatment for OA. The aim of this study is to evaluate
the clinical suitability of infrapatellar fat pad (FP) and synovial ﬂuid (SF)
cells for cartilage repair by determining their MSC-like proﬁle and
response to an inﬂammatory stimulus in vitro.
Methods: Fat pad and synovial ﬂuid were obtained with consent from
the knees of patients undergoing ACI treatment. Cells were isolated
from FP by enzymatic digestion with Collagenase I for 1 h at 37oC fol-
lowed by centrifugation. Synovial ﬂuid cells were obtained by cen-
trifuging the synovial ﬂuid. Resulting cell pellets were seeded onto
tissue culture plastic in DMEM-F12, 10 % FCS and Penicillin/Strepto-
mycin. Expression of cell surface markers was assessed using Flow
cytometry (FACSCanto II). The multipotency of these cells was tested by
culturing in monolayer in osteogenic and adipogenic media. Chondro-
genesis was assessed in 3D pellet culture for 21 days. To evaluate the
immunoresponsive nature of FP and SF cells, the expression of co-
stimulatory markers CD40, CD80, CD86, and Major Histocompatibility
complex II (HLA-DR) was tested before and after stimulation (48 h) with
low (25ng/ml) and high (500ng/ml) concentrations of interferon-g
(IFN-g). Results were compared to those obtained from bone marrow
derived mesenchymal stem cells (BMSCs).
Results: SF and FP cells showed the ability to differentiate down
osteogenic, adipogenic and chondrogenic lineages as shown by positive
alkaline phosphatase (bone), Oil Red O (lipid) and Toluidine blue (gly-
cosaminoglycan) staining.
Cells from both SF and FP were positive for the MSC markers CD73,
CD90, CD105 and negative for HLA-DR. Following stimulation with IFN-
g, both SF and FP cells upregulated CD40 and HLA-DR. In comparison,
BMSCs upregulated HLA-DR after IFN- g stimulation but not the co-
stimulatory marker CD40.
Conclusion: Cells isolated from FP and SF of osteoarthritic joints display
immunogenic properties after stimulation with the pro-inﬂammatory
cytokine IFN-g which may make them unsuitable as alternative cell
sources for ACI. Despite the production of co-stimulatory markers
(CD40) and up regulation of HLA-DR as mentioned above, these cells do
show multipotency via their ability to differentiate down osteogenic,
adipogenic and chondrogenic lineages and they express the MSC
markers CD73, 90 and 105. Their immunoresponsive nature needs to bestudied further before these cells could be considered for routine
applications for cartilage repair.
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DOES MACROPHAGE DEPLETION & CYTOKINE STIMULATION AFFECT
THE PHENOTYPE OF SYNOVIAL MESENCHYMAL PROGENITOR CELLS
IN VITRO?
A. Fichadiya, C. Frank, R. Yates, R. Krawetz. Univ. of Calgary, Calgary, AB,
Canada
Purpose: The aim of the present study was to elucidate the relationship
between synovial mesenchymal progenitor cells (sMPCs) and macro-
phages of the knee joint in OA pathogenesis. Speciﬁcally, this study
sought to assess how components of the macrophage secretome (pro-
and anti-inﬂammatory activation and polarization factors) affect the
chondrogenic capacity of sMPCs in vitro. In addition to this, the effects
of macrophage depletion from OA and normal biopsied human syno-
vium were also assessed.
Methods: Patients with clinical and radiographic OA with no other co-
morbidities consented and had synovial membrane biopsies obtained
during knee arthroplasty or meniscal/ligamentous repair at the Peter
Lougheed Centre, Canada. Synovial ﬂuid and synovial membrane
biopsies from macroscopically normal knees were obtained from
cadavers less the 4 hrs after death. Tissue donors were received by the
Southern Alberta Organ and Tissue Donation Program (SAOTDP). OA
and normal biopsy samples were freshly plated and received 40ng/ml
of IFN-g, TNFa, Il-4, or IL-10, with or without Dichlor-
omethylenediphosphonic acid disodium salt (Clodronate Disodium -
Sigma) in solution every 4 days for 12 days post seeding (clodronate
disodium is a ﬁrst generation bisphosphonate utilized in research for
the depletion of macrophages). Samples of the supernatant are also
collected on days 4, 8, and 12 for proteomic assessment via Luminex.
Following this treated 12 day outgrowth of sMPCs, cells are isolated,
puriﬁed, expanded, and placed in 3 week chondrogenic differentiation
(in pellet culture aggregates). qRT-PCR is conducted thereafter to assess
gene expression levels of chondrogenic factors in addition to qualitative
alcian blue staining.
Results: Our study revealed greater expression levels of Sox9, Col2a and
Aggrecan on sMPCs which came from OA biopsy specimens that
received the clodronate-only treatment in comparison to untreated
biopsy specimens following chondrogenic differentiation. OA Biopsies
which received anti-inﬂammatory cytokines (IL-10 & IL-4) during sMPC
outgrowth also showed greater expression levels of Sox9, Col2a and
Aggrecan following chondrogenic differentiation in comparison to
those receiving pro-inﬂammatory cytokines (IFN-g & TNFa). Addition-
ally, OA biopsies receiving either pro-or anti-inﬂammatory cytokines
alongside clodronate showed variable sMPC expression levels of
chondrogenic factors following differentiation. The TNFa þ Clodronate
group showed the most reduced expression levels in comparison to
sMPCs from untreated biopsies. Normal biopsies which underwent the
same treatment regimens demonstrated similar results in the way of
reduced chondrogenic gene expression following pro-inﬂammatory
exposure, and increased expression following clodronate treatment.
Conclusions: Our ﬁndings shed light on macrophage effects on sMPC
phenotype. Our results demonstrate that depletion of synovial macro-
phages increases the chondrogenic capacity of sMPCs and that pro-
inﬂammatory cytokines which constitute anM1macrophage secretome
